Carillion’s Hold Rating Reaffirmed at Cantor Fitzgerald Europe (CLLN)
Carillion (LON:CLLN)‘s stock had its “hold” rating restated by equities research analysts at Cantor Fitzgerald Europe in a research note issued to investors on Monday, Analyst RN reports. They currently have a GBX 350 ($5.75) price objective on the stock. Cantor Fitzgerald Europe’s price target indicates a potential downside of 1.41% from the stock’s previous close.
Several other analysts have also recently commented on the stock. Analysts at Liberum Capital reiterated a “hold” rating on shares of Carillion in a research note to investors on Friday, January 10th. They now have a GBX 300 ($4.92) price target on the stock. Separately, analysts at JPMorgan Chase & Co. reiterated a “neutral” rating on shares of Carillion in a research note to investors on Wednesday, December 18th. They now have a GBX 300 ($4.92) price target on the stock. Finally, analysts at RBC Capital reiterated an “outperform” rating on shares of Carillion in a research note to investors on Wednesday, December 11th. They now have a GBX 315 ($5.17) price target on the stock. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and four have issued a buy rating to the company’s stock. Carillion presently has a consensus rating of “Hold” and a consensus price target of GBX 312.87 ($5.14).
Shares of Carillion (LON:CLLN) traded up 0.28% during mid-day trading on Monday, hitting GBX 356.00. 713,749 shares of the company’s stock traded hands. Carillion has a 52 week low of GBX 240.00 and a 52 week high of GBX 348.50. The stock’s 50-day moving average is GBX 317.6 and its 200-day moving average is GBX 303.0. The company’s market cap is £1.531 billion.
Carillion plc is an integrated support services company, with a portfolio of public private partnership projects and construction capabilities.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.